Levels of Erythropoietin and Vascular Endothelial Growth Factor in Surgery-Required Advanced Neovascular Glaucoma Eyes Before and After Intravitreal Injection of Bevacizumab

• Published in: Investigative ophthalmology & visual science Vol. 54; no. 6; p. 3874
• Main Authors: Zhou, Minwen, Chen, Shida, Wang, Wei, Huang, Wenbin, Cheng, Bing, Ding, Xiaoyan, Zhang, Xiulan
• Format: Journal Article
• Language: English
• Published: United States 04.06.2013
• Subjects: Aged; Angiogenesis Inhibitors - administration & dosage; Antibodies, Monoclonal, Humanized - administration & dosage; Aqueous Humor - metabolism; Bevacizumab; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Erythropoietin - metabolism; Female; Glaucoma, Neovascular - drug therapy; Glaucoma, Neovascular - metabolism; Humans; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Vascular Endothelial Growth Factor A - metabolism; intravitreal injection of bevacizumab; neovascular glaucoma; vascular endothelial growth factor; erythropoietin
• ISSN: 1552-5783; 1552-5783
• DOI: 10.1167/iovs.12-11507

To evaluate changes of levels of erythropoietin (EPO) and VEGF in aqueous humor before and after an intravitreal injection of bevacizumab (IVB) and determine the underlying correlation between them. This prospective study involved 21 eyes of 21 patients with surgery-required advanced neovascular gla...